Article ID Journal Published Year Pages File Type
10969225 Vaccine 2011 5 Pages PDF
Abstract
To date, via the licence agreement with WHO, the H1N1 LAIV has been transferred to the Government Pharmaceutical Organization in Thailand, the Serum Institute of India, and the Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. in China.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Immunology
Preview
Live attenuated pandemic influenza vaccine: Clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries
Authors
, , , , , , ,